Masecampo, Verlyn D.

HRN: 24-37-59  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/17/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
01/17/2024
01/24/2024
IV
600
Q8
Infected Breast Mass
Waiting Final Action 
01/17/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
01/17/2024
01/24/2024
IV
1.5g
Q6
Infected Breast Mass
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: